Skip to content
image0
jesus-LR
PAPER

An injectable 2.5% cross-linked polyacrylamide hydrogel demonstrates no neurotoxicity in human induced pluripotent stem cells-derived iCell GlutaNeurons

OVERVIEW

This paper documents the establishment and application of an assay to evaluate neurotoxicity and neurite-network changes in human, iPSC-derived glutamatergic neurons after treatment with clinical, polyacrylamide hydrogels.

neurotoxicity-polyacrylamide-hydrogel-thumbnail

RELATED RESOURCES

parkinsons-capabilities-thumbnail-1200x627

APP NOTE

Phenotypic Studies to De-risk Parkinson's Disease R&D

Learn about Parkinson's disease (PD) and review examples of phenotypic studies designed to measure aspects of PD-relevant biology.

alzheimers-capabilities-thumbnail-1200x627

APP NOTE

Phenotypic Studies to De-risk Alzheimer's Disease R&D

Learn more about Alzheimer's disease (AD) and review examples of phenotypic studies designed to measure diverse aspects of AD-relevant biology.

Neurite-outgrowth-NB3OMe-thumbnail-1200x627

CASE STUDY

Neurite Outgrowth in Dopaminergic Neurons in Presence of 251-NB3OMe

Review an example study evaluating the effect of a compound on neurite outgrowth in iPSC-derived dopaminergic neurons.

CONTACT US

Let's discuss how we can help with your next study.

DOWNLOAD THE POSTER

Modeling Neuroinflammatory Diseases with iPSC-derived Microglia

Overview

Microglia contribute to a range of neuroinflammatory and neurodegenerative disorders, but scientists have long suffered from a lack of quality in vitro models for these cells. We have developed a robust and scalable method to produce highly pure, functionally validated, and ready‐to‐use microglia from human induced pluripotent stem cells (iPSC).  This poster shows functionally relevant and measurable phenotypes in these human iPSC‐derived microglia may be suitable for modeling neuroinflammatory diseases and in drug‐screening assays.

In collaboration with BrainXell.

20210108_BrainXell_PVB_SfN21-Microglia-poster-4-1024x768-LR